메뉴 건너뛰기




Volumn 40, Issue 3, 2013, Pages 359-368

Development of a placebo effect model combined with a dropout model for bipolar disorder

Author keywords

Bipolar disorder; Clinical trial simulation; Dropout; Placebo model

Indexed keywords

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; DRUG EFFECT; DRUG RESPONSE; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; PLACEBO EFFECT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STATISTICAL DISTRIBUTION; SURVIVAL TIME; TREATMENT DURATION; YOUNG MANIA RATING SCALE;

EID: 84878754457     PISSN: 1567567X     EISSN: 15738744     Source Type: Journal    
DOI: 10.1007/s10928-013-9305-5     Document Type: Article
Times cited : (12)

References (31)
  • 1
    • 33644992605 scopus 로고    scopus 로고
    • What is bipolar disorder?
    • 16449465 10.1176/appi.ajp.163.2.177
    • Swann AC (2006) What is bipolar disorder? Am J Psychiatry 163(2):177-179
    • (2006) Am J Psychiatry , vol.163 , Issue.2 , pp. 177-179
    • Swann, A.C.1
  • 3
    • 0018175277 scopus 로고
    • A rating scale for mania: Reliability, validity and sensitivity
    • 728692 10.1192/bjp.133.5.429 1:STN:280:DyaE1M%2FotlCktQ%3D%3D
    • Young RC, Biggs JT, Ziegler VE, Meyer DA (1978) A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 133:429-435
    • (1978) Br J Psychiatry , vol.133 , pp. 429-435
    • Young, R.C.1    Biggs, J.T.2    Ziegler, V.E.3    Meyer, D.A.4
  • 4
    • 79958289978 scopus 로고    scopus 로고
    • Structural models describing placebo treatment effects in schizophrenia and other neuropsychiatric disorders
    • 10.2165/11590590-000000000-00000 21651312 10.2165/11590590-000000000- 00000
    • Pilla Reddy V, Kozielska M, Johnson M, Vermeulen A, de Greef R, Liu J, Groothuis GM, Danhof M, Proost JH (2011) Structural models describing placebo treatment effects in schizophrenia and other neuropsychiatric disorders. Clin Pharmacokinet 50(7):429-450. doi: 10.2165/11590590-000000000-00000
    • (2011) Clin Pharmacokinet , vol.50 , Issue.7 , pp. 429-450
    • Pilla Reddy, V.1    Kozielska, M.2    Johnson, M.3    Vermeulen, A.4    De Greef, R.5    Liu, J.6    Groothuis, G.M.7    Danhof, M.8    Proost, J.H.9
  • 5
    • 0033697667 scopus 로고    scopus 로고
    • Prediction of the outcome of a phase 3 clinical trial of an antischizophrenic agent (quetiapine fumarate) by simulation with a population pharmacokinetic and pharmacodynamic model
    • 11103759 10.1067/mcp.2000.110975 1:CAS:528:DC%2BD3cXovVeru7w%3D
    • Kimko HC, Reele SS, Holford NH, Peck CC (2000) Prediction of the outcome of a phase 3 clinical trial of an antischizophrenic agent (quetiapine fumarate) by simulation with a population pharmacokinetic and pharmacodynamic model. Clin Pharmacol Ther 68(5):568-577
    • (2000) Clin Pharmacol Ther , vol.68 , Issue.5 , pp. 568-577
    • Kimko, H.C.1    Reele, S.S.2    Holford, N.H.3    Peck, C.C.4
  • 6
    • 67650608192 scopus 로고    scopus 로고
    • Modeling and simulation of the time course of asenapine exposure response and dropout patterns in acute schizophrenia
    • 19387434 10.1038/clpt.2009.44 1:CAS:528:DC%2BD1MXnsFemtbo%3D
    • Friberg LE, de Greef R, Kerbusch T, Karlsson MO (2009) Modeling and simulation of the time course of asenapine exposure response and dropout patterns in acute schizophrenia. Clin Pharmacol Ther 86(1):84-91
    • (2009) Clin Pharmacol Ther , vol.86 , Issue.1 , pp. 84-91
    • Friberg, L.E.1    De Greef, R.2    Kerbusch, T.3    Karlsson, M.O.4
  • 7
    • 61449255220 scopus 로고    scopus 로고
    • Evaluation of structural models to describe the effect of placebo upon the time course of major depressive disorder
    • 19205853 10.1007/s10928-009-9110-3
    • Shang EY, Gibbs MA, Landen JW, Krams M, Russell T, Denman NG, Mould DR (2009) Evaluation of structural models to describe the effect of placebo upon the time course of major depressive disorder. J Pharmacokinet Pharmacodyn 36(1):63-80
    • (2009) J Pharmacokinet Pharmacodyn , vol.36 , Issue.1 , pp. 63-80
    • Shang, E.Y.1    Gibbs, M.A.2    Landen, J.W.3    Krams, M.4    Russell, T.5    Denman, N.G.6    Mould, D.R.7
  • 8
    • 0026471544 scopus 로고
    • Results and validation of a population pharmacodynamic model for cognitive effects in Alzheimer patients treated with tacrine
    • 1454836 10.1073/pnas.89.23.11471 1:CAS:528:DyaK3sXntlGgtg%3D%3D
    • Holford NH, Peace KE (1992) Results and validation of a population pharmacodynamic model for cognitive effects in Alzheimer patients treated with tacrine. Proc Natl Acad Sci USA 89(23):11471-11475
    • (1992) Proc Natl Acad Sci USA , vol.89 , Issue.23 , pp. 11471-11475
    • Holford, N.H.1    Peace, K.E.2
  • 9
    • 73349136256 scopus 로고    scopus 로고
    • Endpoints and analyses to discern disease-modifying drug effects in early Parkinson's disease
    • 19521783 10.1208/s12248-009-9123-2 1:CAS:528:DC%2BD1MXhsFGmur7M
    • Bhattaram VA, Siddiqui O, Kapcala LP, Gobburu JV (2009) Endpoints and analyses to discern disease-modifying drug effects in early Parkinson's disease. AAPS J 11(3):456-464
    • (2009) AAPS J , vol.11 , Issue.3 , pp. 456-464
    • Bhattaram, V.A.1    Siddiqui, O.2    Kapcala, L.P.3    Gobburu, J.V.4
  • 10
    • 79952576381 scopus 로고    scopus 로고
    • Panel on Handing Missing Data in Clinical Trials, National Research Council The National Academies Press, Washington, DC
    • Panel on Handing Missing Data in Clinical Trials, National Research Council (2010) The prevention and treatment of missing data in clinical trials. The National Academies Press, Washington, DC
    • (2010) The Prevention and Treatment of Missing Data in Clinical Trials
  • 11
    • 58049191296 scopus 로고    scopus 로고
    • Modelling placebo response in depression trials using a longitudinal model with informative dropout
    • 10.1016/j.ejps.2008.10.025 19041717 10.1016/j.ejps.2008.10.025 1:CAS:528:DC%2BD1MXhsFSntg%3D%3D
    • Gomeni R, Lavergne A, Merlo-Pich E (2009) Modelling placebo response in depression trials using a longitudinal model with informative dropout. Eur J pharm Sci 36(1):4-10. doi: 10.1016/j.ejps.2008.10.025
    • (2009) Eur J Pharm Sci , vol.36 , Issue.1 , pp. 4-10
    • Gomeni, R.1    Lavergne, A.2    Merlo-Pich, E.3
  • 12
    • 84878763807 scopus 로고    scopus 로고
    • Clinical trial simulation of outcome after accounting for high dropout typical of acute pain studies
    • Paper presented, Chicago
    • Dutta S, Diderichsen P, Liu W (2011) Clinical trial simulation of outcome after accounting for high dropout typical of acute pain studies. Paper presented at the American College of Clinical Pharmacology 40th Annual Meeting, Chicago
    • (2011) American College of Clinical Pharmacology 40th Annual Meeting
    • Dutta, S.1    Diderichsen, P.2    Liu, W.3
  • 13
    • 0038402581 scopus 로고    scopus 로고
    • A joint model for nonlinear longitudinal data with informative dropout
    • 12800808 10.1023/A:1023249510224
    • Hu C, Sale ME (2003) A joint model for nonlinear longitudinal data with informative dropout. J Pharmacokinet Pharmacodyn 30(1):83-103
    • (2003) J Pharmacokinet Pharmacodyn , vol.30 , Issue.1 , pp. 83-103
    • Hu, C.1    Sale, M.E.2
  • 16
    • 65249191379 scopus 로고    scopus 로고
    • Quantitative disease, drug, and trial models
    • 10.1146/annurev.pharmtox.011008.145613 18851702 10.1146/annurev.pharmtox. 011008.145613 1:CAS:528:DC%2BD1MXisV2jsb8%3D
    • Gobburu JV, Lesko LJ (2009) Quantitative disease, drug, and trial models. Annu Rev Pharmacol Toxicol 49:291-301. doi: 10.1146/annurev.pharmtox.011008. 145613
    • (2009) Annu Rev Pharmacol Toxicol , vol.49 , pp. 291-301
    • Gobburu, J.V.1    Lesko, L.J.2
  • 17
    • 79953756267 scopus 로고    scopus 로고
    • Estimating transformations for repeated measures modeling of continuous bounded outcome data
    • doi: 10.1002/sim.4155
    • Hutmacher MM, French JL, Krishnaswami S, Menon S (2011) Estimating transformations for repeated measures modeling of continuous bounded outcome data. Stat Med. doi: 10.1002/sim.4155
    • (2011) Stat Med.
    • Hutmacher, M.M.1    French, J.L.2    Krishnaswami, S.3    Menon, S.4
  • 18
    • 80052591773 scopus 로고    scopus 로고
    • Bounded outcome score modeling: Application to treating psoriasis with ustekinumab
    • 10.1007/s10928-011-9205-5 21688068 10.1007/s10928-011-9205-5 1:CAS:528:DC%2BC3MXovVyntbo%3D
    • Hu C, Yeilding N, Davis HM, Zhou H (2011) Bounded outcome score modeling: application to treating psoriasis with ustekinumab. J Pharmacokinet Pharmacodyn 38(4):497-517. doi: 10.1007/s10928-011-9205-5
    • (2011) J Pharmacokinet Pharmacodyn , vol.38 , Issue.4 , pp. 497-517
    • Hu, C.1    Yeilding, N.2    Davis, H.M.3    Zhou, H.4
  • 19
    • 41149144295 scopus 로고    scopus 로고
    • Mechanisms of placebo and placebo-related effects across diseases and treatments
    • 10.1146/annurev.pharmtox.48.113006.094711 17666008 10.1146/annurev. pharmtox.48.113006.094711 1:CAS:528:DC%2BD1cXisFynurg%3D
    • Benedetti F (2008) Mechanisms of placebo and placebo-related effects across diseases and treatments. Annu Rev Pharmacol Toxicol 48:33-60. doi: 10.1146/annurev.pharmtox.48.113006.094711
    • (2008) Annu Rev Pharmacol Toxicol , vol.48 , pp. 33-60
    • Benedetti, F.1
  • 20
    • 34247325672 scopus 로고    scopus 로고
    • Bayesian modelling and ROC analysis to predict placebo responders using clinical score measured in the initial weeks of treatment in depression trials
    • 10.1111/j.1365-2125.2006.02815.x 17488364 10.1111/j.1365-2125.2006.02815. x
    • Gomeni R, Merlo-Pich E (2007) Bayesian modelling and ROC analysis to predict placebo responders using clinical score measured in the initial weeks of treatment in depression trials. Br J Clin Pharmacol 63(5):595-613. doi: 10.1111/j.1365-2125.2006.02815.x
    • (2007) Br J Clin Pharmacol , vol.63 , Issue.5 , pp. 595-613
    • Gomeni, R.1    Merlo-Pich, E.2
  • 21
    • 67651171223 scopus 로고    scopus 로고
    • Elucidation of relationship between tumor size and survival in non-small-cell lung cancer patients can aid early decision making in clinical drug development
    • 19440187 10.1038/clpt.2009.64 1:CAS:528:DC%2BD1MXovFOrt7o%3D
    • Wang Y, Sung C, Dartois C, Ramchandani R, Booth BP, Rock E, Gobburu J (2009) Elucidation of relationship between tumor size and survival in non-small-cell lung cancer patients can aid early decision making in clinical drug development. Clin Pharmacol Ther 86(2):167-174
    • (2009) Clin Pharmacol Ther , vol.86 , Issue.2 , pp. 167-174
    • Wang, Y.1    Sung, C.2    Dartois, C.3    Ramchandani, R.4    Booth, B.P.5    Rock, E.6    Gobburu, J.7
  • 22
    • 47149107776 scopus 로고    scopus 로고
    • Approaches to handling pharmacodynamic baseline responses
    • 10.1007/s10928-008-9088-2 18446428 10.1007/s10928-008-9088-2 1:CAS:528:DC%2BD1cXosVGiu74%3D
    • Dansirikul C, Silber HE, Karlsson MO (2008) Approaches to handling pharmacodynamic baseline responses. J Pharmacokinet Pharmacodyn 35(3):269-283. doi: 10.1007/s10928-008-9088-2
    • (2008) J Pharmacokinet Pharmacodyn , vol.35 , Issue.3 , pp. 269-283
    • Dansirikul, C.1    Silber, H.E.2    Karlsson, M.O.3
  • 23
    • 50349085673 scopus 로고    scopus 로고
    • Identifying patterns in treatment response profiles in acute bipolar mania: A cluster analysis approach
    • 18664256 10.1186/1471-244X-8-65
    • Lipkovich IA, Houston JP, Ahl J (2008) Identifying patterns in treatment response profiles in acute bipolar mania: a cluster analysis approach. BMC Psychiatry 8:65
    • (2008) BMC Psychiatry , vol.8 , pp. 65
    • Lipkovich, I.A.1    Houston, J.P.2    Ahl, J.3
  • 24
    • 84867862609 scopus 로고    scopus 로고
    • Catechol-O-methyltransferase val158met polymorphism predicts placebo effect in irritable bowel syndrome
    • 10.1371/journal.pone.0048135 23110189 10.1371/journal.pone.0048135 1:CAS:528:DC%2BC38Xhs1Gjt7fE
    • Hall KT, Lembo AJ, Kirsch I, Ziogas DC, Douaiher J, Jensen KB, Conboy LA, Kelley JM, Kokkotou E, Kaptchuk TJ (2012) Catechol-O-methyltransferase val158met polymorphism predicts placebo effect in irritable bowel syndrome. PLoS One 7(10):e48135. doi: 10.1371/journal.pone.0048135
    • (2012) PLoS One , vol.7 , Issue.10 , pp. 48135
    • Hall, K.T.1    Lembo, A.J.2    Kirsch, I.3    Ziogas, D.C.4    Douaiher, J.5    Jensen, K.B.6    Conboy, L.A.7    Kelley, J.M.8    Kokkotou, E.9    Kaptchuk, T.J.10
  • 25
    • 57049188862 scopus 로고    scopus 로고
    • Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD
    • 10.1016/j.euroneuro.2008.08.009 18823760 10.1016/j.euroneuro.2008.08.009 1:CAS:528:DC%2BD1cXhsVKrsb7N
    • Papakostas GI, Fava M (2009) Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD. Eur Neuropsychopharmacol 19(1):34-40. doi: 10.1016/j.euroneuro.2008.08.009
    • (2009) Eur Neuropsychopharmacol , vol.19 , Issue.1 , pp. 34-40
    • Papakostas, G.I.1    Fava, M.2
  • 26
    • 77950328267 scopus 로고    scopus 로고
    • Does inclusion of a placebo arm influence response to active antidepressant treatment in randomized controlled trials? Results from pooled and meta-analyses
    • 10.4088/JCP.08r04516blu 20122371 10.4088/JCP.08r04516blu 1:CAS:528:DC%2BC3cXlsFSjsr8%3D
    • Sinyor M, Levitt AJ, Cheung AH, Schaffer A, Kiss A, Dowlati Y, Lanctot KL (2010) Does inclusion of a placebo arm influence response to active antidepressant treatment in randomized controlled trials? Results from pooled and meta-analyses. J Clin psychiatry 71(3):270-279. doi: 10.4088/JCP.08r04516blu
    • (2010) J Clin Psychiatry , vol.71 , Issue.3 , pp. 270-279
    • Sinyor, M.1    Levitt, A.J.2    Cheung, A.H.3    Schaffer, A.4    Kiss, A.5    Dowlati, Y.6    Lanctot, K.L.7
  • 27
    • 0032733161 scopus 로고    scopus 로고
    • Unbalanced randomization influences placebo response: Scientific versus ethical issues around the use of placebo in migraine trials
    • 10570722 10.1046/j.1468-2982.1999.019008699.x 1:STN:280: DC%2BD3c%2FjsleisA%3D%3D
    • Diener HC, Dowson AJ, Ferrari M, Nappi G, Tfelt-Hansen P (1999) Unbalanced randomization influences placebo response: scientific versus ethical issues around the use of placebo in migraine trials. Cephalalgia 19(8):699-700
    • (1999) Cephalalgia , vol.19 , Issue.8 , pp. 699-700
    • Diener, H.C.1    Dowson, A.J.2    Ferrari, M.3    Nappi, G.4    Tfelt-Hansen, P.5
  • 28
    • 79951579481 scopus 로고    scopus 로고
    • Signal detection and placebo response in schizophrenia: Parallels with depression
    • 20581800
    • Mallinckrodt CH, Zhang L, Prucka WR, Millen BA (2010) Signal detection and placebo response in schizophrenia: parallels with depression. Psychopharmacol Bull 43(1):53-72
    • (2010) Psychopharmacol Bull , vol.43 , Issue.1 , pp. 53-72
    • Mallinckrodt, C.H.1    Zhang, L.2    Prucka, W.R.3    Millen, B.A.4
  • 29
    • 79956339016 scopus 로고    scopus 로고
    • The placebo response in clinical trials: More questions than answers
    • 10.1098/rstb.2010.0384 21576146 10.1098/rstb.2010.0384
    • Enck P, Klosterhalfen S, Weimer K, Horing B, Zipfel S (2011) The placebo response in clinical trials: more questions than answers. Philos Trans R Soc Lond B Biol Sci 366(1572):1889-1895. doi: 10.1098/rstb.2010.0384
    • (2011) Philos Trans R Soc Lond B Biol Sci , vol.366 , Issue.1572 , pp. 1889-1895
    • Enck, P.1    Klosterhalfen, S.2    Weimer, K.3    Horing, B.4    Zipfel, S.5
  • 30
    • 79955486643 scopus 로고    scopus 로고
    • Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications
    • 10.4088/JCP.10m06191 21527123 10.4088/JCP.10m06191
    • Khin NA, Chen YF, Yang Y, Yang P, Laughren TP (2011) Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications. J Clin Psychiatry 72(4):464-472. doi: 10.4088/JCP.10m06191
    • (2011) J Clin Psychiatry , vol.72 , Issue.4 , pp. 464-472
    • Khin, N.A.1    Chen, Y.F.2    Yang, Y.3    Yang, P.4    Laughren, T.P.5
  • 31
    • 84863550159 scopus 로고    scopus 로고
    • Exploratory analyses of efficacy data from schizophrenia trials in support of new drug applications submitted to the US Food and Drug Administration
    • 10.4088/JCP.11r07539 22687813 10.4088/JCP.11r07539
    • Khin NA, Chen YF, Yang Y, Yang P, Laughren TP (2012) Exploratory analyses of efficacy data from schizophrenia trials in support of new drug applications submitted to the US Food and Drug Administration. J Clin Psychiatry 73(6):856-864. doi: 10.4088/JCP.11r07539
    • (2012) J Clin Psychiatry , vol.73 , Issue.6 , pp. 856-864
    • Khin, N.A.1    Chen, Y.F.2    Yang, Y.3    Yang, P.4    Laughren, T.P.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.